AI Summary

Review shows majority of procedures offered alongside standard IVF not backed by reliable evidence Most IVF “add-on” treatments sold to people hoping to boost their chances of having children are not backed by reliable evidence, fail to boost fertility and may be a complete waste of money, the largest study of its kind has concluded. There has been a surge in extra procedures, medicines or techniques offered to patients in addition to standard IVF with bold claims they will increase the probability of success. Take-up is widespread, with more than 70% of IVF patients in the UK, Australia and New Zealand paying for one or more add-on during IVF treatment. Acupuncture – inserting thin needles into points on the body. Corticosteroids – medication to reduce inflammation and suppress immune system activity. Endometrial receptivity testing – a biopsy of the uterine lining to assess gene expression patterns. Intralipid infusion – a liquid containing fats that is administered into the blood. Intraovarian injection of platelet-rich plasma – injecting platelet-rich plasma into the ovaries. Intrauterine infusion of platelet-rich plasma – insertion of platelet-rich plasma into the uterus. Pre-implantation genetic testing for aneuploidy – a screening test to check whether embryos have the expected number of chromosomes. EmbryoGlue – an embryo transfer medium containing hyaluronic acid. The evidence review found it may increase the probability of pregnancy and live birth; however, the effect on live birthrates was not robust. Endometrial scratching – a minor procedure undertaken to scratch or disturb the lining of the uterus. The review found this may increase the probability of pregnancy and live birth. Physiological intracytoplasmic sperm injection (PICSI) – a technique used to select sperm based on their ability to bind to hyaluronic acid. There was weak evidence this may lower the risk of miscarriage. Continue reading...

AI summaries can be wrong sometimes—always verify important details using the source article.